IM Cannabis Sells European Operations to Strengthen Balance Sheet
Event summary
- IM Cannabis completed the sale of IMC Holdings and its European-focused operations to Slil.com Holding Ltd. on September 29, 2026.
- The transaction included a C$3 million advance payment and the transfer of retained liabilities capped at C$9.4 million.
- IM Cannabis expects the deal to improve shareholders' equity by approximately C$3 million.
- The company will now focus on its Israeli medical cannabis operations.
- The transaction was approved by a special committee of independent directors.
The big picture
IM Cannabis's sale of its European operations marks a strategic pivot to streamline its corporate structure and reduce liabilities. The move comes amid financial difficulties and reflects a broader trend in the cannabis industry of companies focusing on core markets to improve profitability. The transaction's success will depend on the company's ability to leverage its retained Israeli operations and navigate regulatory challenges.
What we're watching
- Financial Impact
- Whether the C$3 million improvement in shareholders' equity will materialize as expected and how it affects the company's liquidity position.
- Operational Focus
- How IM Cannabis's shift to focus on Israeli medical cannabis operations will impact its market position and growth prospects.
- Regulatory Compliance
- The company's ability to maintain or regain compliance with Nasdaq's continued listing requirements following the transaction.